Investigational Site Number :1580001

Taichung 407

3 studies enrolling now · 8 studies all time

What they study most

Breast Cancer, Breast Cancer Metastatic, Factor VIII Deficiency, Focal Segmental Glomerulosclerosis, Gastric Cancer, Glomerulonephritis Minimal Lesion, Hemophilia A, Lung Neoplasm Malignant, Neoplasm, Neoplasm Malignant, Pancreatic Carcinoma Metastatic, Plasma Cell Myeloma

Studies at this site

• A Study to Evaluate the Efficacy and Safety of Frexalimab, Brivekimig, or Rilzabrutinib in Participants Aged 16 to 75 Years With Primary Focal Segmental Glomerulosclerosis or Minimal Change Disease — Recruiting now
• Efanesoctocog Alfa Prophylaxis in Patients With Hemophilia A With Synovial Hypertrophy — Recruiting now
• International Treatment-extension Study in Adult Participants With Multiple Myeloma and Who Have Derived Clinical Benefit From Isatuximab — Enrolling by invitation
• Long-term Safety and Efficacy of Efanesoctocog Alfa (BIVV001) in Previously Treated Patients With Hemophilia A — Running, not enrolling
• Tusamitamab Ravtansine Monotherapy and in Combination in Patients With CEACAM5-positive Advanced Solid Tumors — Stopped early
• Dose Escalation and Expansion Study of SAR443216 in Participants With Relapsed/Refractory HER2 Expressing Solid Tumors — Stopped early
• Safety, Efficacy and PK of BIVV001 in Pediatric Patients With Hemophilia A — Completed
• A Medical Research Study Designed to Determine if Venglustat Can be a Future Treatment for ADPKD Patients — Stopped early